In this study we assessed the feasibility of quantitative parameters derived from amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in predicting the response to transcatheter arterial chemoembolization (TACE) treatment for hypervascular hepatocellular carcinoma (HCC). The combination model of quantitative parameters of APT and DKI showed good diagnostic performance in predicting the recurrence and postoperative liver decompensation. Therefore, APT and DKI can be used as potential imaging biomarkers to predict the effect of early-stage HCC after TACE treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords